Aspartoacylase suppresses prostate cancer progression by blocking LYN activation

BACKGROUND: Globally, despite prostate cancer (PCa) representing second most prevalent malignancy in male, the precise molecular mechanisms implicated in its pathogenesis remain unclear. Consequently, elucidating the key molecular regulators that govern disease progression could substantially contri...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Hong, Xiong, Kang-Ping, Wang, Wang, Qian, Kai-Yu, Yuan, Shuai, Wang, Gang, Yu, Fang, Luo, Jun, Lu, Meng-Xin, Yang, Zhong-Hua, Liu, Tao, Huang, Xing, Zheng, Hang, Wang, Xing-Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240701/
https://www.ncbi.nlm.nih.gov/pubmed/37271807
http://dx.doi.org/10.1186/s40779-023-00460-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240701/
https://www.ncbi.nlm.nih.gov/pubmed/37271807
http://dx.doi.org/10.1186/s40779-023-00460-0

Ejemplares similares